| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 15.75 | 12.9% | 12.6% |
| Total Income | 15.75 | 12.9% | 12.6% |
| Expenditure | 47.40 | 24.8% | 12.3% |
| PBT | -40.97 | 26.0% | 6.1% |
| Net Profit | -40.97 | 27.7% | 6.8% |
| OPM | — | ||
| NPM | — | ||
| EPS | -0.30 | 40.0% | 28.6% |
ADC Therapeutics SA Reports Q2 2025 Financial Results
04 May 2026 · 4 May, 7:31 am
Summary
The press release announces ADC Therapeutics SA's financial results for the second quarter ended September 30, 2025. Further details are available in Exhibit 99.1.
Informational and educational content only. Not investment advice.